Eyepoint to present at guggenheim smid cap biotech conference

Watertown, mass., jan. 30, 2025 (globe newswire) -- eyepoint pharmaceuticals, inc. (nasdaq: eypt), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that jay s. duker, m.d., president and chief executive officer of eyepoint will participate in a fireside chat at the guggenheim smid cap biotech conference on thursday, february 6, 2025 at 9:30 a.m. et.
SMID Ratings Summary
SMID Quant Ranking